| Protein | Synonyms | Taxonomy |
|---|
| Elongation of very long chain fatty acids protein 7 | EC 2.3.1.199; 3-keto acyl-CoA synthase ELOVL7; ELOVL fatty acid elongase 7; ELOVL FA elongase 7; Very long chain 3-ketoacyl-CoA synthase 7; Very long chain 3-oxoacyl-CoA synthase 7 | Homo sapiens (human) |
| Trifunctional enzyme subunit alpha, mitochondrial | 78 kDa gastrin-binding protein; Monolysocardiolipin acyltransferase; 2.3.1.-; TP-alpha | Homo sapiens (human) |
| Prostaglandin reductase 2 | PRG-2; EC 1.3.1.48; 15-oxoprostaglandin 13-reductase; Zinc-binding alcohol dehydrogenase domain-containing protein 1 | Homo sapiens (human) |
| Very long-chain acyl-CoA synthetase | VLACS; VLCS; EC 6.2.1.-; Arachidonate--CoA ligase; 6.2.1.15; Fatty acid transport protein 2; FATP-2; Fatty-acid-coenzyme A ligase, very long-chain 1; Long-chain-fatty-acid--CoA ligase; 6.2.1.3; Phytanate--CoA ligase; 6.2.1.24; Solute carrier family 27 mem | Homo sapiens (human) |
| Fatty-acid amide hydrolase 1 | EC 3.5.1.99; Anandamide amidohydrolase 1; Fatty acid ester hydrolase; 3.1.1.-; Oleamide hydrolase 1 | Homo sapiens (human) |
| Prostaglandin E synthase | EC 5.3.99.3; Glutathione peroxidase PTGES; 1.11.1.-; Glutathione transferase PTGES; 2.5.1.18; Microsomal glutathione S-transferase 1-like 1; MGST1-L1; Microsomal prostaglandin E synthase 1; MPGES-1; p53-induced gene 12 protein | Homo sapiens (human) |
| Solute carrier family 22 member 5 | High-affinity sodium-dependent carnitine cotransporter; Organic cation/carnitine transporter 2 | Homo sapiens (human) |
| Polyunsaturated fatty acid 5-lipoxygenase | EC 1.13.11.-; Arachidonate 5-lipoxygenase; 5-LO; 5-lipoxygenase; 1.13.11.34 | Homo sapiens (human) |
| Arachidonate 5-lipoxygenase-activating protein | FLAP; MK-886-binding protein | Homo sapiens (human) |
| Prostaglandin G/H synthase 1 | EC 1.14.99.1; Cyclooxygenase-1; COX-1; Prostaglandin H2 synthase 1; PGH synthase 1; PGHS-1; PHS 1; Prostaglandin-endoperoxide synthase 1 | Homo sapiens (human) |
| Multidrug resistance-associated protein 1 | EC 7.6.2.2; ATP-binding cassette sub-family C member 1; Glutathione-S-conjugate-translocating ATPase ABCC1; 7.6.2.3; Leukotriene C(4) transporter; LTC4 transporter | Homo sapiens (human) |
| Prostaglandin G/H synthase 2 | EC 1.14.99.1; Cyclooxygenase-2; COX-2; PHS II; Prostaglandin H2 synthase 2; PGH synthase 2; PGHS-2; Prostaglandin-endoperoxide synthase 2 | Homo sapiens (human) |
| Aldo-keto reductase family 1 member C3 | EC 1.1.1.-; EC 1.1.1.210; EC 1.1.1.53; EC 1.1.1.62; 17-beta-hydroxysteroid dehydrogenase type 5; 17-beta-HSD 5; 3-alpha-HSD type II, brain; 3-alpha-hydroxysteroid dehydrogenase type 2; 3-alpha-HSD type 2; 1.1.1.357; Chlordecone reductase homolog HAKRb; Di | Homo sapiens (human) |
| MAP kinase-activated protein kinase 2 | MAPK-activated protein kinase 2; MAPKAP kinase 2; MAPKAP-K2; MAPKAPK-2; MK-2; MK2; EC 2.7.11.1 | Homo sapiens (human) |
| Fatty acid synthase | EC 2.3.1.85; Type I fatty acid synthase | Homo sapiens (human) |
| Stearoyl-CoA desaturase 5 | EC 1.14.19.1; Acyl-CoA-desaturase 4; HSCD5; Stearoyl-CoA 9-desaturase; Stearoyl-CoA desaturase 2 | Homo sapiens (human) |
| Peroxisomal carnitine O-octanoyltransferase | COT; EC 2.3.1.137 | Homo sapiens (human) |
| Malonate--CoA ligase ACSF3, mitochondrial | EC 6.2.1.n3; Acyl-CoA synthetase family member 3 | Homo sapiens (human) |
| Enoyl-CoA hydratase, mitochondrial | EC 4.2.1.17; Enoyl-CoA hydratase 1; Short-chain enoyl-CoA hydratase; SCEH | Homo sapiens (human) |
| Trifunctional enzyme subunit beta, mitochondrial | TP-beta | Homo sapiens (human) |
| ATP-citrate synthase | EC 2.3.3.8; ATP-citrate (pro-S-)-lyase; ACL; Citrate cleavage enzyme | Homo sapiens (human) |
| Stearoyl-CoA desaturase | hSCD1; EC 1.14.19.1; Acyl-CoA desaturase; Delta(9)-desaturase; Delta-9 desaturase; Fatty acid desaturase | Homo sapiens (human) |
| Hematopoietic prostaglandin D synthase | H-PGDS; EC 5.3.99.2; GST class-sigma; Glutathione S-transferase; 2.5.1.18; Glutathione-dependent PGD synthase; Glutathione-requiring prostaglandin D synthase; Prostaglandin-H2 D-isomerase | Homo sapiens (human) |
| Leukotriene A-4 hydrolase | LTA-4 hydrolase; EC 3.3.2.6; Leukotriene A(4) hydrolase; Tripeptide aminopeptidase LTA4H; 3.4.11.4 | Homo sapiens (human) |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 12/15-lipoxygenase; Arachidonate 12-lipoxygenase, leukocyte-type; 12-LOX; 1.13.11.31; Arachidonate 15-lipoxygenase; 15-LOX; 15-LOX-1; 1.13.11.33; Arachidonate omega-6 lipoxygenase; Hepoxilin A3 synthase Alox15; 1.13.11.-; Linoleate 13S-lipoxygenase; 1.13. | Homo sapiens (human) |
| Carbonyl reductase [NADPH] 1 | EC 1.1.1.184; 15-hydroxyprostaglandin dehydrogenase [NADP(+)]; 1.1.1.196; 1.1.1.197; 20-beta-hydroxysteroid dehydrogenase; NADPH-dependent carbonyl reductase 1; Prostaglandin 9-ketoreductase; PG-9-KR; Prostaglandin-E(2) 9-reductase; 1.1.1.189; Short chain | Homo sapiens (human) |
| Retinoic acid receptor RXR-alpha | Nuclear receptor subfamily 2 group B member 1; Retinoid X receptor alpha | Homo sapiens (human) |
| Thromboxane-A synthase | TXA synthase; TXS; EC 5.3.99.5; Cytochrome P450 5A1; Hydroperoxy icosatetraenoate dehydratase; 4.2.1.152 | Homo sapiens (human) |
| Bifunctional epoxide hydrolase 2 | | Homo sapiens (human) |
| Peroxisome proliferator-activated receptor delta | PPAR-delta; NUCI; Nuclear hormone receptor 1; NUC1; Nuclear receptor subfamily 1 group C member 2; Peroxisome proliferator-activated receptor beta; PPAR-beta | Homo sapiens (human) |
| Acetyl-CoA carboxylase 1 | ACC1; EC 6.4.1.2; Acetyl-Coenzyme A carboxylase alpha; ACC-alpha | Homo sapiens (human) |
| Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | MCAD; EC 1.3.8.7; Medium chain acyl-CoA dehydrogenase; MCADH | Homo sapiens (human) |
| Long-chain-fatty-acid--CoA ligase 1 | EC 6.2.1.3; Acyl-CoA synthetase 1; ACS1; Arachidonate--CoA ligase; 6.2.1.15; Long-chain acyl-CoA synthetase 1; LACS 1; Long-chain acyl-CoA synthetase 2; LACS 2; Long-chain fatty acid-CoA ligase 2; Palmitoyl-CoA ligase 1; Palmitoyl-CoA ligase 2; Phytanate- | Homo sapiens (human) |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | VLCAD; EC 1.3.8.9 | Homo sapiens (human) |
| Serum paraoxonase/lactonase 3 | EC 3.1.1.2; EC 3.1.1.81; EC 3.1.8.1 | Homo sapiens (human) |
| Acyl-CoA dehydrogenase family member 10 | ACAD-10; EC 1.3.99.- | Homo sapiens (human) |
| Dipeptidase 1 | EC 3.4.13.19; Beta-lactamase; 3.5.2.6; Dehydropeptidase-I; Microsomal dipeptidase; Renal dipeptidase; hRDP | Homo sapiens (human) |
| Propionyl-CoA carboxylase alpha chain, mitochondrial | PCCase subunit alpha; EC 6.4.1.3; Propanoyl-CoA:carbon dioxide ligase subunit alpha | Homo sapiens (human) |
| Propionyl-CoA carboxylase beta chain, mitochondrial | PCCase subunit beta; EC 6.4.1.3; Propanoyl-CoA:carbon dioxide ligase subunit beta | Homo sapiens (human) |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 15-lipoxygenase 2; 15-LOX-2; Arachidonate 15-lipoxygenase B; 15-LOX-B; 1.13.11.33; Arachidonate 15-lipoxygenase type II; Linoleate 13-lipoxygenase 15-LOb; 1.13.11.- | Homo sapiens (human) |
| Acyl-CoA (8-3)-desaturase | EC 1.14.19.44; Delta(5) fatty acid desaturase; D5D; Delta(5) desaturase; Delta-5 desaturase; Fatty acid desaturase 1 | Homo sapiens (human) |
| Acyl-CoA 6-desaturase | EC 1.14.19.3; Delta(6) fatty acid desaturase; D6D; Delta(6) desaturase; Delta-6 desaturase; Fatty acid desaturase 2 | Homo sapiens (human) |
| Serum paraoxonase/arylesterase 1 | PON 1; EC 3.1.1.2; EC 3.1.1.81; EC 3.1.8.1; Aromatic esterase 1; A-esterase 1; K-45; Serum aryldialkylphosphatase 1 | Homo sapiens (human) |
| Elongation of very long chain fatty acids protein 2 | EC 2.3.1.199; 3-keto acyl-CoA synthase ELOVL2; ELOVL fatty acid elongase 2; ELOVL FA elongase 2; Very long chain 3-ketoacyl-CoA synthase 2; Very long chain 3-oxoacyl-CoA synthase 2 | Homo sapiens (human) |
| Mitochondrial carnitine/acylcarnitine carrier protein | Carnitine/acylcarnitine translocase; CAC; Solute carrier family 25 member 20 | Homo sapiens (human) |
| Fatty-acid amide hydrolase 2 | EC 3.5.1.99; Amidase domain-containing protein; Anandamide amidohydrolase 2; Oleamide hydrolase 2 | Homo sapiens (human) |
| Lysosomal thioesterase PPT2 | PPT-2; EC 3.1.2.-; S-thioesterase G14 | Homo sapiens (human) |
| Enoyl-CoA delta isomerase 1, mitochondrial | EC 5.3.3.8; 3,2-trans-enoyl-CoA isomerase; Delta(3),Delta(2)-enoyl-CoA isomerase; D3,D2-enoyl-CoA isomerase; Dodecenoyl-CoA isomerase | Homo sapiens (human) |
| Alpha-methylacyl-CoA racemase | EC 5.1.99.4; 2-methylacyl-CoA racemase | Homo sapiens (human) |
| Dipeptidase 2 | EC 3.4.13.19 | Homo sapiens (human) |
| Dipeptidase 3 | EC 3.4.13.19 | Homo sapiens (human) |
| Acyl carrier protein, mitochondrial | ACP; CI-SDAP; NADH-ubiquinone oxidoreductase 9.6 kDa subunit | Homo sapiens (human) |
| Arachidonate 12-lipoxygenase, 12R-type | 12R-LOX; 12R-lipoxygenase; EC 1.13.11.-; Epidermis-type lipoxygenase 12 | Homo sapiens (human) |
| Phosphatidylcholine transfer protein | PC-TP; START domain-containing protein 2; StARD2; StAR-related lipid transfer protein 2 | Homo sapiens (human) |
| 5'-AMP-activated protein kinase subunit beta-2 | AMPK subunit beta-2 | Homo sapiens (human) |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | 15-PGDH; EC 1.1.1.141; Prostaglandin dehydrogenase 1; Short chain dehydrogenase/reductase family 36C member 1 | Homo sapiens (human) |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | EC 1.13.11.-; Arachidonate (12S)-lipoxygenase; 12S-LOX; 12S-lipoxygenase; 1.13.11.31; Arachidonate (15S)-lipoxygenase; 1.13.11.33; Linoleate (13S)-lipoxygenase; Lipoxin synthase 12-LO; 3.3.2.-; Platelet-type lipoxygenase 12 | Homo sapiens (human) |
| Carnitine O-palmitoyltransferase 2, mitochondrial | EC 2.3.1.21; Carnitine palmitoyltransferase II; CPT II | Homo sapiens (human) |
| Cytosolic phospholipase A2 | cPLA2; Phospholipase A2 group IVA | Homo sapiens (human) |
| Palmitoyl-protein thioesterase 1 | PPT-1; EC 3.1.2.22; Palmitoyl-protein hydrolase 1 | Homo sapiens (human) |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | AMPK subunit alpha-2; EC 2.7.11.1; Acetyl-CoA carboxylase kinase; ACACA kinase; 2.7.11.27; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase; 2.7.11.31 | Homo sapiens (human) |
| Leukotriene C4 synthase | LTC4 synthase; EC 4.4.1.20; Glutathione S-transferase LTC4; 2.5.1.-; Leukotriene-C(4) synthase; Leukotriene-C4 synthase | Homo sapiens (human) |
| Acyl-CoA wax alcohol acyltransferase 1 | EC 2.3.1.75; Diacylglycerol O-acyltransferase 2-like protein 3; Diacylglycerol acyltransferase 2; Long-chain-alcohol O-fatty-acyltransferase 1 | Homo sapiens (human) |
| Hydroxyacid oxidase 2 | HAOX2; EC 1.1.3.15; (S)-2-hydroxy-acid oxidase, peroxisomal; Cell growth-inhibiting gene 16 protein; Long chain alpha-hydroxy acid oxidase; Long-chain L-2-hydroxy acid oxidase | Homo sapiens (human) |
| 5'-AMP-activated protein kinase subunit gamma-2 | AMPK gamma2; AMPK subunit gamma-2; H91620p | Homo sapiens (human) |
| Glutathione hydrolase 1 proenzyme | EC 3.4.19.13; Gamma-glutamyltransferase 1; Gamma-glutamyltranspeptidase 1; GGT 1; 2.3.2.2; Leukotriene-C4 hydrolase; 3.4.19.14 | Homo sapiens (human) |
| Carnitine O-acetyltransferase | Carnitine acetylase; EC 2.3.1.137; EC 2.3.1.7; Carnitine acetyltransferase; CAT; CrAT | Homo sapiens (human) |
| Phytanoyl-CoA dioxygenase, peroxisomal | EC 1.14.11.18; Phytanic acid oxidase; Phytanoyl-CoA alpha-hydroxylase; PhyH | Homo sapiens (human) |
| Peroxisomal bifunctional enzyme | PBE; PBFE; L-bifunctional protein; LBP; Multifunctional enzyme 1; MFE1 | Homo sapiens (human) |
| Peroxisomal multifunctional enzyme type 2 | MFE-2; 17-beta-hydroxysteroid dehydrogenase 4; 17-beta-HSD 4; D-bifunctional protein; DBP; Multifunctional protein 2; MFP-2; Short chain dehydrogenase/reductase family 8C member 1 | Homo sapiens (human) |
| Prostaglandin-H2 D-isomerase | EC 5.3.99.2; Beta-trace protein; Cerebrin-28; Glutathione-independent PGD synthase; Lipocalin-type prostaglandin-D synthase; L-PGDS; Prostaglandin-D2 synthase; PGD2 synthase; PGDS; PGDS2 | Homo sapiens (human) |
| Prostaglandin reductase 1 | PRG-1; 15-oxoprostaglandin 13-reductase; 1.3.1.48; Dithiolethione-inducible gene 1 protein; D3T-inducible gene 1 protein; DIG-1; Leukotriene B4 12-hydroxydehydrogenase; NAD(P)H-dependent alkenal/one oxidoreductase; 1.3.1.74 | Homo sapiens (human) |
| Enoyl-[acyl-carrier-protein] reductase, mitochondrial | EC 1.3.1.104; 2-enoyl thioester reductase; Nuclear receptor-binding factor 1; HsNrbf-1; NRBF-1 | Homo sapiens (human) |
| Methylmalonyl-CoA epimerase, mitochondrial | EC 5.1.99.1; DL-methylmalonyl-CoA racemase | Homo sapiens (human) |
| Peroxisomal acyl-coenzyme A oxidase 2 | EC 1.17.99.3; 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase; 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase; Trihydroxycoprostanoyl-CoA oxidase; THCA-CoA oxidase; THCCox | Homo sapiens (human) |
| Sterol carrier protein 2 | SCP-2; Acetyl-CoA C-myristoyltransferase; 2.3.1.155; Non-specific lipid-transfer protein; NSL-TP; Propanoyl-CoA C-acyltransferase; 2.3.1.176; SCP-2/3-oxoacyl-CoA thiolase; SCP-2/thiolase; 2.3.1.16; SCP-chi; SCPX; Sterol carrier protein X; SCP-X; Straight- | Homo sapiens (human) |
| Peroxisomal acyl-coenzyme A oxidase 3 | EC 1.3.3.6; Branched-chain acyl-CoA oxidase; BRCACox; Pristanoyl-CoA oxidase | Homo sapiens (human) |
| Serum paraoxonase/arylesterase 2 | PON 2; EC 3.1.1.2; EC 3.1.1.81; Aromatic esterase 2; A-esterase 2; Serum aryldialkylphosphatase 2 | Homo sapiens (human) |
| Acyl-CoA dehydrogenase family member 11 | ACAD-11; EC 1.3.8.- | Homo sapiens (human) |
| Malonyl-CoA-acyl carrier protein transacylase, mitochondrial | MCT; EC 2.3.1.39; Mitochondrial malonyl CoA:ACP acyltransferase; Mitochondrial malonyltransferase; [Acyl-carrier-protein] malonyltransferase | Homo sapiens (human) |
| Short-chain specific acyl-CoA dehydrogenase, mitochondrial | SCAD; EC 1.3.8.1; Butyryl-CoA dehydrogenase | Homo sapiens (human) |
| Acyl-coenzyme A thioesterase 8 | Acyl-CoA thioesterase 8; EC 3.1.2.1; EC 3.1.2.11; EC 3.1.2.2; EC 3.1.2.3; EC 3.1.2.5; Choloyl-coenzyme A thioesterase; 3.1.2.27; HIV-Nef-associated acyl-CoA thioesterase; Peroxisomal acyl-CoA thioesterase 2; PTE-2; Peroxisomal acyl-coenzyme A thioester hy | Homo sapiens (human) |
| S-acyl fatty acid synthase thioesterase, medium chain | EC 3.1.2.14; Augmented in rheumatoid arthritis 1; AURA1; Oleoyl-ACP hydrolase; Thioesterase 2; TE2; Thioesterase II; Thioesterase domain-containing protein 1 | Homo sapiens (human) |
| Long-chain specific acyl-CoA dehydrogenase, mitochondrial | LCAD; EC 1.3.8.8 | Homo sapiens (human) |
| Thyroid hormone-inducible hepatic protein | Spot 14 protein; S14; SPOT14 | Homo sapiens (human) |
| Hydroxyacyl-thioester dehydratase type 2, mitochondrial | HsHTD2; EC 4.2.1.59; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase | Homo sapiens (human) |
| ATP-binding cassette sub-family D member 1 | EC 7.6.2.4; Adrenoleukodystrophy protein; ALDP | Homo sapiens (human) |
| Prostamide/prostaglandin F synthase | Prostamide/PG F synthase; Prostamide/PGF synthase; EC 1.11.1.20; Peroxiredoxin-like 2B; Protein FAM213B | Homo sapiens (human) |
| Medium-chain acyl-CoA ligase ACSF2, mitochondrial | EC 6.2.1.2 | Homo sapiens (human) |
| Nucleoside diphosphate-linked moiety X motif 19 | Nudix motif 19; EC 3.6.1.- | Homo sapiens (human) |
| Peroxisomal membrane protein PMP34 | 34 kDa peroxisomal membrane protein; Solute carrier family 25 member 17 | Homo sapiens (human) |
| 3-ketoacyl-CoA thiolase, peroxisomal | EC 2.3.1.16; Acetyl-CoA C-myristoyltransferase; 2.3.1.155; Acetyl-CoA acyltransferase; 2.3.1.9; Beta-ketothiolase; Peroxisomal 3-oxoacyl-CoA thiolase | Homo sapiens (human) |
| Peroxisomal coenzyme A diphosphatase NUDT7 | EC 3.6.1.-; Nucleoside diphosphate-linked moiety X motif 7; Nudix motif 7 | Homo sapiens (human) |
| Glutathione hydrolase 5 proenzyme | EC 3.4.19.13; Gamma-glutamyl transpeptidase-related enzyme; GGT-rel; Gamma-glutamyltransferase 5; GGT 5; 2.3.2.2; Gamma-glutamyltransferase-like activity 1; Gamma-glutamyltranspeptidase 5; Leukotriene-C4 hydrolase; 3.4.19.14 | Homo sapiens (human) |
| 3-ketoacyl-CoA thiolase, mitochondrial | EC 2.3.1.16; Acetyl-CoA acetyltransferase; 2.3.1.9; Acetyl-CoA acyltransferase; Acyl-CoA hydrolase, mitochondrial; 3.1.2.-; 3.1.2.1; 3.1.2.2; Beta-ketothiolase; Mitochondrial 3-oxoacyl-CoA thiolase; T1 | Homo sapiens (human) |
| 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial | EC 1.3.1.124; 2,4-dienoyl-CoA reductase [NADPH]; 4-enoyl-CoA reductase [NADPH]; Short chain dehydrogenase/reductase family 18C member 1 | Homo sapiens (human) |
| Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | HCDH; EC 1.1.1.35; Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase; Short-chain 3-hydroxyacyl-CoA dehydrogenase | Homo sapiens (human) |
| Solute carrier family 27 member 3 | EC 6.2.1.-; Arachidonate--CoA ligase; 6.2.1.15; Long-chain fatty acid transport protein 3; FATP-3; Fatty acid transport protein 3; Very long-chain acyl-CoA synthetase homolog 3; VLCS-3 | Homo sapiens (human) |
| Carbonyl reductase family member 4 | EC 1.-.-.-; 3-ketoacyl-[acyl-carrier-protein] reductase beta subunit; KAR beta subunit; 3-oxoacyl-[acyl-carrier-protein] reductase; 1.1.1.-; Quinone reductase CBR4; Short chain dehydrogenase/reductase family 45C member 1 | Homo sapiens (human) |
| Estradiol 17-beta-dehydrogenase 8 | EC 1.1.1.62; 17-beta-hydroxysteroid dehydrogenase 8; 17-beta-HSD 8; 3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit; KAR alpha subunit; 3-oxoacyl-[acyl-carrier-protein] reductase; 1.1.1.-; Protein Ke6; Ke-6; Really interesting new gene 2 protein | Homo sapiens (human) |
| Acyl-CoA-binding domain-containing protein 6 | | Homo sapiens (human) |
| Peroxisomal trans-2-enoyl-CoA reductase | TERP; EC 1.3.1.38; 2,4-dienoyl-CoA reductase-related protein; DCR-RP; HPDHase; Short chain dehydrogenase/reductase family 29C member 1; pVI-ARL | Homo sapiens (human) |
| Hydroperoxide isomerase ALOXE3 | Epidermis-type lipoxygenase 3; Epidermal LOX-3; e-LOX-3; eLOX-3; Hydroperoxy dehydratase ALOXE3; Hydroperoxy icosatetraenoate dehydratase; 4.2.1.152; Hydroperoxy icosatetraenoate isomerase; 5.4.4.7 | Homo sapiens (human) |
| Mid1-interacting protein 1 | Gastrulation-specific G12-like protein; Mid1-interacting G12-like protein; Protein STRAIT11499; Spot 14-related protein; S14R; Spot 14-R | Homo sapiens (human) |
| Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] | pDCR; EC 1.3.1.124; 2,4-dienoyl-CoA reductase 2; Short chain dehydrogenase/reductase family 17C member 1 | Homo sapiens (human) |
| Acyl-coenzyme A oxidase-like protein | Acyl-CoA oxidase-like protein; EC 1.3.3.- | Homo sapiens (human) |
| 2-hydroxyacyl-CoA lyase 1 | EC 4.1.2.n2; 2-hydroxyphytanoyl-CoA lyase; 2-HPCL; Phytanoyl-CoA 2-hydroxylase 2 | Homo sapiens (human) |
| ATPase MORC2 | EC 3.6.1.-; MORC family CW-type zinc finger protein 2; Zinc finger CW-type coiled-coil domain protein 1 | Homo sapiens (human) |
| Compound | Description |
|---|
| hydronium ion | |
| n-Butyrate | |
| Glutathione | A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. |
| Thiamine Pyrophosphate | The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX. |
| Succinate | |
| acetic acid | Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) |
| NADH | |
| Calcium | A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. |
| iron | A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. |
| Carbon Dioxide | A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. |
| citric acid, anhydrous | |
| Zinc | A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn. |
| Orthophosphate | |
| Glutathione Disulfide | A GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized. |
| tretinoin | An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). |
| dinoprostone | The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. |
| dinoprost | A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. |
| linoleic acid | A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed) |
| alpha-linolenic acid | A fatty acid that is found in plants and involved in the formation of prostaglandins. |
| epoprostenol | A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). |
| adenosine diphosphate | Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. |
| hydrogen carbonate | |
| Hydrogen Peroxide | A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. |
| Magnesium | A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION. |
| Sodium | A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. |
| Water | A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) |
| Oxygen | An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. |
| palmitic acid | A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids. |
| succinyl-coenzyme A | |
| 1,5-dihydro-FAD | chromophore component of E coli DNA photolyase |
| hexanoyl-coenzyme A | |
| salicylates | The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. |
| stearidonic acid | RN given refers to cpd with unknown MF; 18:4 n-3 fatty acid |
| cobamamide | |
| propionylcarnitine | RN given refers to cpd without isomeric designation |
| malondialdehyde | The dialdehyde of malonic acid. |
| palmitoylcarnitine | A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. |
| 3-oxopristanoyl-coenzyme A | |
| phytanoyl-coenzyme A | |
| s-tetradecanoyl-coenzyme a | |
| hydroxyphytanoyl-coenzyme A | an intermediate in the alpha-oxidation of phytanic acid in rat liver peroxisomes; its formation is enhanced by dioxygenase cofactors |
| pristanal | structure given in first source |
| adenosine monophosphate | Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. |
| nad | A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) |
| NADP | Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) |
| NADP | Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) |
| alpha-Ketoglutarate | |
| Oxaloacetate | An anionic form of oxaloacetic acid. |
| decanoyl-coenzyme A | |
| formate | |
| carnitine | A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. |
| formyl-coenzyme a | |
| 3-ketohexanoyl-coenzyme A | |
| prostaglandin h2 | A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. |
| octanoyl-coenzyme A | |
| n(1)-methylnicotinamide | RN given refers to parent cpd |
| leukotriene a4 | (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
| leukotriene b4 | The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) |
| leukotriene c4 | The conjugation product of LEUKOTRIENE A4 and glutathione. It is the major arachidonic acid metabolite in macrophages and human mast cells as well as in antigen-sensitized lung tissue. It stimulates mucus secretion in the lung, and produces contractions of nonvascular and some VASCULAR SMOOTH MUSCLE. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
| thromboxane a2 | An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). |
| 15-keto-5,8,11,13-eicosatetraenoic acid | RN given refers to (E,Z,Z,Z)-isomer; RN for cpd without isomeric designation not available 3/88 |
| 15-hydroxy-5,8,11,13-eicosatetraenoic acid | potent & selective inhibitor of platelet lipoxygenase; RN given refers to cpd without isomeric designation |
| 5-hydroxy-6,8,11,14-eicosatetraenoic acid | |
| 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid | RN given refers to (S-(R*,R*-(E,E,Z,Z)))-isomer |
| arachidonic acid 5-hydroperoxide | 5-HPETE is used inconsistently in literature as syn for cpds with various tetraene locants; RN given refers to (6,8,11,14)-isomer; RN in CA Vol 91 Form Index for (E,Z,Z,Z)-isomer: 70968-82-0; RN for (5,8,11,13)-isomer: 71133-12-5; in Merck, arachidonic acid is the (5,8,11,14)-isomer |
| 12-oxoleukotriene B4 | structure given in first source |
| 20-carboxyleukotriene b4 | metabolite of leukotriene B4 |
| leukotriene d4 | One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
| leukotriene e4 | A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
| prostaglandin a2 | RN given refers to (5Z,13E,15S)-isomer |
| prostaglandin b2 | RN given refers to (5Z,13E,15S)-isomer |
| prostaglandin g2 | |
| 9-deoxy-delta-9-prostaglandin d2 | has potent antineoplastic & weak smooth muscle contracting activities; structure given in first source |
| 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2 | PGD2 metabolite in human plasma |
| Dinoprost | A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. |
| 6-ketoprostaglandin f1 alpha | The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. |
| 11-dehydro-thromboxane b2 | structure given in first source |
| arachidonic acid omega-9 hydroperoxide | |
| 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (s)-(e,z,z,z)-isomer | |
| anandamide | |
| thromboxane b2 | A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). |
| 12-hydroxy-5,8,10-heptadecatrienoic acid | metabolite of arachidonic acid in blood platelet suspension; RN given refers to cpd without isomeric designation |
| 12-hydroxy-5,8,10,14-eicosatetraenoic acid | A lipoxygenase metabolite of ARACHIDONIC ACID. It is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumor cell metastatic potential through activation of protein kinase C. (J Pharmacol Exp Ther 1995; 274(3):1545-51; J Natl Cancer Inst 1994; 86(15):1145-51) |
| 20-hydroxy-5,8,11,14-eicosatetraenoic acid | stimulator of renal sodium, potassium atpase; RN given is for the (all-Z) isomer |
| 5-oxo-6,8,11,14-eicosatetraenoic acid | RN given is for cpd without isomeric designation; an arachidonate metabolite which stimulates neutrophils to mobilize Ca and promotes PMN degranulation responses |
| 12-keto-5,8,11,13-eicosatetraenoic acid | |
| 15-hydroxy-5,8,11,13-eicosatetraenoic acid | potent & selective inhibitor of platelet lipoxygenase; RN given refers to cpd without isomeric designation |
| 5,6-epoxy-8,11,14-eicosatrienoic acid | RN given refers to cpd without isomeric designation |
| 8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid | |
| 15-deoxy-delta(12,14)-prostaglandin j2 | 15-deoxy-PGJ2 is also available; check for double bonds (indicated by delta) at 12 and 14 positions |
| glutamate | |
| adenosine triphosphate | An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. |
| oleoyl-coenzyme a | RN given refers to (Z)-isomer |
| linoleoyl-coenzyme A | RN from 9th CI Form Index & given refers to cpd without isomeric designation |
| 18-carboxy-19,20-dinorleukotriene B4 | structure given in first source |
| 2,4-decadienoyl-coenzyme A | |
| 20-aldehyde leukotriene B4 | |
| ethanolamine | A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases. |
| 2-hydroxyhexadecanoic acid | RN given refers to cpd without isomeric designation |
| 3-hydroxybutyryl-coenzyme A, (S)-isomer | |
| 5-hydroxy-6,8,11,14-eicosatetraenoic acid | |
| behenyl-coenzyme A | |
| beta-ketohexadecanoyl-coenzyme A | |
| 19-hydroxy-5,8,11,14-eicosatetraenoic acid | potent stimulator of renal sodium, potassium atpase; RN given is for the (all-Z) isomer |
| pristanic acid | |
| 4-decenoyl-coenzyme A | |
| 3-hydroxyoctadecanoyl-coenzyme A | |
| Coenzyme A | |
| lauroyl-coenzyme A | |
| lignoceroyl-coenzyme A | |
| arachidonyl-coenzyme A | |
| 3-ketostearoyl-coenzyme A | |
| phytanic acid | A 20-carbon branched chain fatty acid. In phytanic acid storage disease (REFSUM DISEASE) this lipid may comprise as much as 30% of the total fatty acids of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency. |
| decanoic acid | |
| eoxin c4 | structure in first source |
| eoxin D4 | |
| prostaglandin d2 | The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. |
| acetoacetyl CoA | |
| Acetyl Coenzyme A | Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. |
| butyryl-coenzyme A | |
| Palmitoyl Coenzyme A | A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis. |
| Malonyl Coenzyme A | A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems. |
| stearoyl-coenzyme A | |
| Flavin-Adenine Dinucleotide | A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) |
| eoxin E4 | |
| creolin | from refined coal tar oils |
| propionyl-coenzyme a | RN given refers to parent cpd |